KOSTANTO Canadian Trademark Information
Pharmaceuticals products for the treatment of central nervous system named encephalitis, epilepsy, Alzeimer's disease, cerebral palsy, Parkinson's diseases, infections of the central nervous system, brain diseases, locomotor disorders of the central nervous system, sleep disorders, depression, multiples sclerosis slabs, for the prevention and treatment of thrombosis, for the prevention and treatment of oncology Pharmaceuticals products for the treatment of central nervous system named encephalitis, epilepsy, Alzeimer's disease, cerebral palsy, Parkinson's diseases, infections of the central nervous system, brain diseases, locomotor disorders of the central nervous system, sleep disorders, depression, multiples sclerosis slabs, for the prevention and treatment of thrombosis, for the prevention and treatment of oncology
Perfect for these industries
Words that describe this mark
pharmaceuticals products treatment central nervous named encephalitis epilepsy alzeimers disease cerebral palsy parkinsons diseases infections central nervous brain diseases locomotor disorders central nervous sleep disorders depression multiples
Abandonment Notice!
On Wednesday, August 22, 2018,
status on the KOSTANTO
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Thursday, July 30, 2015, a canadian trademark registration was filed for
KOSTANTO by SANOFI, une société anonyme *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1739664.
The current status of this trademark filing is Interruption of proceeding.
The KOSTANTO
trademark is filed in the description of
Pharmaceuticals products for the treatment of central nervous system named encephalitis, epilepsy, Alzeimer's disease, cerebral palsy, Parkinson's diseases, infections of the central nervous system, brain diseases, locomotor disorders of the central nervous system, sleep disorders, depression, multiples sclerosis slabs, for the prevention and treatment of thrombosis, for the prevention and treatment of oncology
,
Pharmaceuticals products for the treatment of central nervous system named encephalitis, epilepsy, Alzeimer's disease, cerebral palsy, Parkinson's diseases, infections of the central nervous system, brain diseases, locomotor disorders of the central nervous system, sleep disorders, depression, multiples sclerosis slabs, for the prevention and treatment of thrombosis, for the prevention and treatment of oncology
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.